42,714.29
0.00 BRL
28.48 B BRL
200.34 B BRL
About Abbott Laboratories
Sector
Industry
CEO
Robert B. Ford
Website
Headquarters
Abbott Park
Founded
1888
ISIN
BRABTTBDR007
FIGI
BBG002Q24FQ6
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
ABBOT COVID TRIANGLE BREAKOUTABBOT has been a really bad boy but it eventually put itself in some kind of triangle.
Will it break out? I think so.
PRICE TARGET 103$
STOP LOSS: There is no stop loss!
Abbott TrendsAfter showing a bull trend that lasted several years the stock has moved to bearish teritorry in the past year. During this time the stock price has been range bound between 36 and 46. It is showing resistance at 36 levels. The relative strength of the stock when compared to the S&P 500 is indicatin
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where ABTT34 is featured.
